Adjuvant therapy for women over age 65 with breast cancer;Adjuvante therapie des mammakarzinoms bei patientinnen über 65 jahre

Deutsches Arzteblatt

Volumn 108, Issue 21, 2011, Pages 365-371

  Sautter Bihl, Marie Luise ^a   Souchon, Rainer ^b   Gerber, Bernd ^c  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE; CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; AGED; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMAN; LIFE EXPECTANCY; MEDICAL SOCIETY; MEDLINE; META ANALYSIS (TOPIC); MULTIPLE CYCLE TREATMENT; ONCOLOGY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TOXICITY; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PROGNOSIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE;

EID: 79960447687     PISSN: 00121207     EISSN: 01722107     Source Type: Journal    
DOI: 10.3238/arztebl.2011.0365     Document Type: Review

References (26)

1. Bouchardy C, Rapiti E, Fioretta G, et al.: Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003; 21: 3580-7. (Pubitemid 46594049)
2. Hancke K, Denkinger MD, König J, et al.: Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol 2010; 21: 748-53.
3. Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML: Breast cancer treatment guidelines in older women. J Clin Oncol 2005; 23: 783-91. (Pubitemid 46224177)
4. Wildiers H, Kunkler I, Biganzoli L, et al.: Management of breast cancer in elderly individuals: recommendations of the International Society Geriatric Oncology. Lancet Oncology 2007; 8: 1101-5.
5. Deutsche Krebsgesellschaft e.V.: Interdisziplinäre S3-Leitlinien für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms - 1.
6. Aktualisierung 2008. München: Zuckschwerdt, 2008; 74-81 www.senologie.org/leitlinien.htm
7. AGO, Arbeitsgemeinschaft Gynäkologische Onkologie. Empfehlungen Gynäkologische Onkologie - Kommission Mamma. www.agoonline. org/Leitlinien
8. Sautter-Bihl ML, Budach W, Dunst J, et al.: DEGRO practical guidelines for radiotherapy of breast cancer I. Breast-conserving therapy. Strahlenther Onkol 2007; 183: 661-6. (Pubitemid 350175416)
9. Sautter-Bihl ML, Souchon R, Budach W, et al.: DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Strahlenther Onkol 2008; 184: 347-53.
10. NCCN, National Comprehensive Cancer Network. Clinical practice guidelines in oncology: Breast cancer - Version V.1.2010. Practice Guidelines in Oncology 2010. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83. (Pubitemid 17055592)
12. Balducci L, Extermann M, Carreca I: Management of breast cancer in the older women. Cancer Control 2001; 8: 431-41. (Pubitemid 32916875)
13. Extermann M, Aapro M, Bernabei R, et al.: Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005; 55: 241-52. (Pubitemid 41219694)
14. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001; 285: 885-92. (Pubitemid 32171549)
15. Diab SG, Elledge RM, Clark GM: Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000; 92: 550-6. (Pubitemid 30212316)
16. Singh R, Hellmann S, Heimann R: The natural history of breast carcinoma in the elderly. Cancer 2004; 100: 1807-13.
17. Deutsch M: Radiotherapy after lumpectomy for breast cancer in very old women. Am J Clin Oncol 2002; 25: 48-9.
18. Muss HB, Berry DA, Cirrincione CT, et al.: Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2009; 360: 2055-65.
19. Fargeot P, Bonneterre J, Roché H, et al.: Disease-free survivial advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French Adjuvant Study Group 08 Trial. J Clin Oncol 2004; 22: 4674-82.
20. Aapro M, Monfardini S, Jirillo A, Basso U: Management of primary and advanced breast cancer in older unfit patients (medical treatment). Cancer Treat Rev 2009; 35: 503-8.
21. Clarke M, Collins R, Darby S, et al.: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106. (Pubitemid 41797643)
22. Fyles AW, McCready DR, Manchul LA, et al.: Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004; 351: 963-70.
23. Truong PT, Bernstein V, Lesperance M, Speers CH, Olivotto JA: Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg 2006; 191: 749-55. (Pubitemid 43729395)
24. Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS: Use and outcomes of adjuvant chemotherapy in older women with breast cancer: J Clin Oncol 2006; 24: 2750-6. (Pubitemid 46630572)
25. Crivellari D, Bonetti M, Castiglione-Gertsch M, et al.: Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and Tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII. J Clin Oncol 2000; 18: 1412-22. (Pubitemid 30205386)
26. Smith I, Procter M, Gelber RD, et al.: For the herceptin adjuvant (HERA) study team. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 2007; 369: 29-36.